Abstract
Background
The effect of income status on patient outcome merits investigation during periods of financial crisis. We evaluated the impact of income status on out-of-hospital prognosis in a cohort of acute coronary syndrome (ACS) patients, included in a countrywide study during a period of financial crisis.
Methods
The study is a secondary analysis of a prospective, multicenter, observational study–the PHAETHON study—enrolling consecutive ACS patients in 37 hospitals in Greece. Patients were classified as low or high income based on the reported net annual household income using as a cut-off point the relative poverty threshold for Greece of 12,000 Euros. The outcome measure was survival free of the primary composite endpoint (cardiovascular death, myocardial infarction, stroke/transient ischemic attack, urgent revascularization and urgent hospitalization due to cardiovascular causes).
Results
The study population included 794 patients. The administration rate of evidence-based medications was similar in the low- (n = 455) and high-income (n = 339) groups during hospitalization and upon discharge. In a median follow-up of 189 days (interquartile range: 180–212 days), low-income patients had 92 % higher risk of the combined endpoint as compared to high-income patients [Hazard ratio (HR):1.92, 95 % CI:1.25–2.94, p = 0.003]. The effect of low-income status on the combined outcome remained significant after adjustment for age, gender and depression (HR:1.59, 95 % CI:1.02–2.49; p = 0.043).
Conclusions
In a period of financial crisis, low income is a significant and independent predictor of poor out-of-hospital outcome in ACS patients. This association has profound implications and should be taken into consideration by public health policy makers.
Similar content being viewed by others
References
Ndrepepa G, Tada T, Fusaro M et al (2012) Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clin Res Cardiol 101(12):1003–1011
Sinning C, Lillpopp L, Appelbaum S et al (2013) Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application. Clin Res Cardiol 102(7):495–503
Jakobsen L, Niemann T, Thorsgaard N et al (2012) Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary intervention. Circ Cardiovasc Interv 5(5):641–648
Alter DA, Naylor CD, Austin P, Tu JV (1999) Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 341:1359–1367
Rao SV, Schulman KA, Curtis LH, Gersh BJ, Jollis JG (2004) Socioeconomic status and outcome following acute myocardial infarction in elderly patients. Arch Intern Med 164:1128–1133
Tonne C, Schwartz J, Mittleman M, Melly S, Suh H, Goldberg R (2005) Long-term survival after acute myocardial infarction is lower in more deprived neighborhoods. Circulation 111:3063–3070
Gemmill MC, Thomson S, Mossialos E (2008) What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries. Int J Equity Health 7:12
Karanikolos M, Mladovsky P, Cylus J et al (2013) Financial crisis, austerity, and health in Europe. Lancet 381:1323–1331
Wagstaff A, van Doorslaer E, Calonge S et al (1992) Equity in the finance of health care: some international comparisons. J Health Econ 11:361–387
http://appsso.eurostat.ec.europa.eu/nui/submitViewTableAction.do—Eurostat At-risk-of-poverty thresholds (source SILC)
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial (2012) Third universal definition of MI. Eur Heart J 33:2551–2567
Salomaa V, Niemelä M, Miettinen H et al (2000) Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study. Circulation 101:1913–1918
Salomaa V, Miettinen H, Niemelä M et al (2001) Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register Study. J Epidemiol Community Health 55:475–482
Macintyre K, Stewart S, Chalmers J et al (2001) Relation between socioeconomic deprivation and death from a first myocardial infarction in Scotland: population based analysis. BMJ 322:1152–1153
Morrison C, Woodward M, Leslie W, Tunstall-Pedoe H (1997) Effect of socioeconomic group on incidence of, management of, and survival after myocardial infarction and coronary death: analysis of community coronary event register. BMJ 314:541–546
Wang JY, Wang CY, Juang SY et al (2014) Low socioeconomic status increases short-term mortality of acute myocardial infarction despite universal health coverage. Int J Cardiol 172:82–87
van Lenthe FJ, Schrijvers CT, Droomers M, Joung IM, Louwman MJ, Mackenbach JP (2004) Investigating explanations of socio-economic inequalities in health: the Dutch GLOBE study. Eur J Public Health 14:63–70
Rathore SS, Berger AK, Weinfurt KP et al (2000) Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly. Circulation 102:642–648
Ferreira-González I, Marsal JR, Ribera A et al (2010) Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation. Circulation 122:1017–1025
Goldman DP, Joyce GF, Zheng Y (2007) Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA 298:61–69
Philipson TJ, Mozaffari E, Maclean JR (2010) Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndrome. Am J Manag Care 16:290–297
Davlouros P, Gizas V, Stavrou K, Raptis G, Alexopoulos D (2013) DES thrombosis related to antiplatelet therapy noncompliance: a consequence of the Greek financial crisis. Int J Cardiol 168:4497–4499
Alan S, Crossley TF, Grootendorst P, Veall MR (2005) Distributional effects of “general population” prescription drug programs in Canada. Can J Econ 38:128–148
Funding
The study was supported by a grant from Astrazeneca. The funding source had no involvement in the study design, the collection, analysis and interpretation of data, in the writing of the report and in the decision to submit the article for publication. This work was undertaken and supported by the Hellenic Cardiovascular Research Society.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Appendix
Appendix
Principal investigators: Professor Panos Vardas, Dr. George Andrikopoulos.
Study coordinators: Stylianos Tzeis, Dimitrios Terentes-Printzios.
Participating centers and investigators
-
1.
Patras University Hospital, Patras: A. Siapika, K. Stavrou, P. Theodorou, D. Alexopoulos.
-
2.
Henry Dunant Hospital Center, Athens: I. Nastas, S. Pastromas, S. Tzeis, G. Andrikopoulos.
-
3.
General Hospital of Mytilini, Mytilini: G. Varlamos, P. Andronikos.
-
4.
University Hospital of Heraklion: I. Saloustros, P. Vardas.
-
5.
General Hospital Larissa: K. Ntoulas, F. Vasiliou.
-
6.
AHEPA University Hospital, Thessaloniki: A. Megarisiotou, K. Dimitriou, V. Vasilikos.
-
7.
Komotini General Hospital: E. Gidaris, A. Gotsis.
-
8.
University Hospital of Ioannina: G. Liappas, I. Goudevenos.
-
9.
Venizeleio General Hospital, Heraklion: A. Dermitzakis.
-
10.
General Hospital of Corfu: N. Kalantzis, A. Draganigos.
-
11.
General Hospital of Kalamata: I. Pisimisis, S. Zompolos.
-
12.
Attikon University Hospital, Athens: F. Kolokathis, I. Koniari, E. Iliodromitis.
-
13.
Papageorgiou General Hospital, Thessaloniki: D. Efthimiou V. Sahpekidis.
-
14.
Skylitsion General Hospital, Chios: E. Papatheodorou, A. Kartalis, G. Georgiopoulos, N. Smirnioudis.
-
15.
General Hospital Agia Varvara, Attica: D. Kontogianni, A. Kranidis.
-
16.
2nd IKA Hospital, Thessaloniki: C. Kyrpizidis.
-
17.
Bodosakeio General Hospital of Ptolemaida: S. Lampropoulos.
-
18.
Sotiria Thoracic Diseases Hospital, Athens: N. Marinakis, S. Limperi.
-
19.
General Hospital of Halkida: V. Falireas, K. Toli, I. Mantas.
-
20.
Asklipio General Hospital of Voula: N. Xiotelis, A. Giannakopoulos, A. Daskalaki, A. Manolis.
-
21.
General Hospital of Sparti: M. Driva, S. Mavridis.
-
22.
General Hospital of Edessa: J. Karadoumanis, K. Oikonomou.
-
23.
Thriasio General Hospital, Elefsina: G. Psarou, C. Olympios.
-
24.
Konstantopoulio General Hospital, Athens: A. Anadiotis, S. Patsilinakos.
-
25.
Chania General Hospital: C. Kaukala, A. Pras.
-
26.
Euroclinic Hospital of Athens: G. Goumas, D. Richter.
-
27.
General Hospital of Preveza: D. Padazis, G. Sakka.
-
28.
General Hospital of Thiva: M. Scoubourdis.
-
29.
University Hospital of Alexandroupolis: D. Stakos.
-
30.
Hippokration University Hospital Athens: D. Terentes-Printzios, C. Vlachopoulos, X. Stefanadis.
-
31.
General Hospital of Aigio: A. Ampousamala, I. Siclimiris, I. Stiliadis.
-
32.
General Hospital of Kavala: A. Chatzipapatheodoridis, N. Kampouridis, D. Simeonidis.
-
33.
University Hospital of Larissa: M. Dalapasxa, F. Triposkiadis.
-
34.
Volos General Hospital: K. Anastasiou, T. Tsaknakis.
-
35.
Tzaneio General Hospital of Piraeus: A. Destounis, S. Foussas.
-
36.
Hippokration General Hospital, Thessaloniki: K. Rossios, N. Fragakis.
-
37.
General Hospital of Tripoli: A. Giannoulis, D. Chrissos.
Rights and permissions
About this article
Cite this article
Andrikopoulos, G., Tzeis, S., Terentes-Printzios, D. et al. Impact of income status on prognosis of acute coronary syndrome patients during Greek financial crisis. Clin Res Cardiol 105, 518–526 (2016). https://doi.org/10.1007/s00392-015-0948-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-015-0948-7